Ladenburg Thalmann Financial Services’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$173K Hold
1,825
﹤0.01% 2620
2019
Q3
$205K Buy
1,825
+200
+12% +$15.9K ﹤0.01% 2445
2019
Q2
$102K Buy
1,625
+500
+44% +$32.4K ﹤0.01% 2959
2019
Q1
$74K Buy
1,125
+100
+10% +$5.58K ﹤0.01% 3117
2018
Q4
$37K Hold
1,025
﹤0.01% 3475
2018
Q3
$53K Buy
1,025
+500
+95% +$20.6K ﹤0.01% 3279
2018
Q2
$25K Hold
525
﹤0.01% 3707
2018
Q1
$25K Buy
+525
New +$30.7K ﹤0.01% 3707

Other funds holding VNRX

Ladenburg Thalmann Financial Services's VNRX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its VolitionRx Ltd (VNRX) position steady in Q4 2019 at 1,825 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Ladenburg Thalmann Financial Services first reported a position in VNRX in Q1 2018 and has held it in 8 quarters since. The position peaked at $205K in Q3 2019. 36 funds tracked by Wall St. Rank hold VNRX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,825 shares of VolitionRx Ltd worth $173K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its VolitionRx Ltd share count unchanged in Q4 2019.
  • VolitionRx Ltd made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2620 holding.
  • Ladenburg Thalmann Financial Services first reported a position in VolitionRx Ltd in Q1 2018 and has held it in 8 quarters since.
  • Ladenburg Thalmann Financial Services's VolitionRx Ltd position peaked at $205K in Q3 2019.
  • 36 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.